isatin has been researched along with Neurodegenerative Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkinepally, R; Garige, AK; Garlapati, A; Kulkarni, R; Macha, B; Palabindala, R | 1 |
| Dominguez, C; Gemkow, MJ; Krieger, F; Maillard, MC; Muñoz-Sanjuán, I; Park, H; Schaertl, S; Winkler, D | 1 |
2 other study(ies) available for isatin and Neurodegenerative Diseases
| Article | Year |
|---|---|
Design, Synthesis and Biological Evaluation of New Cycloalkyl Fused Quinolines Tethered to Isatin Schiff Bases as Cholinesterase Inhibitors.
Topics: Acetylcholinesterase; Aged; Alzheimer Disease; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Isatin; Molecular Docking Simulation; Neurodegenerative Diseases; Quinolines; Schiff Bases; Structure-Activity Relationship | 2022 |
A label-free LC/MS/MS-based enzymatic activity assay for the detection of genuine caspase inhibitors and SAR development.
Topics: Caspase 2; Caspase 3; Caspase 6; Caspase Inhibitors; Chromatography, Liquid; Drug Design; Enzyme Assays; Isatin; Neurodegenerative Diseases; Oligopeptides; Tandem Mass Spectrometry | 2013 |